• Conference Recording
  • On-Demand
  • Practice Management
We are at a unique place in obesity care history where anti-obesity medications (AOMs) are showing promising, clinically significant weight loss for persons with obesity.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
This session with review the relationship and underlying mechanisms between obesity and cardiovascular disease with attention to the individual variability between BMI and CV risk.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
Weight stigma is an often-overlooked contributor to poor patient engagement and weight gain over time.
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
This presentation will provide an overview of the evidence basis for using continuous glucose monitoring (CGM) in patients with obesity.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Adiposity Related Diseases
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
In this session, Liz Paul will describe her experiences living with obesity, including her journey to overcoming internalized weight bias.
  • 0.75 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Special Populations
Obesity is a disease that disproportionately affects women. Those from ethnic/racial minorities and those who live in poverty are often more severely affected.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Practice Management
OMA Clinical Practice Statement Updates - Harold Bays, MD, FOMA, Lydia Alexander, MD, FOMA, Karlijn Burridge, PA-C, Suzanne Cuda, MDCME/CE Expiration Date: 3/19/25
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Pharmacotherapy
Over the last decade, the FDA has approved five new medications for the treatment of obesity. The latest edition, semaglutide, published impressive weight loss results and we are just beginning.
  • 1.00 AMA PRA Category 1 Credit
  • Conference Recording
  • On-Demand
  • Behavioral Modification
Discussing obesity with patients can be challenging. Motivational interviewing (MI) is and effective way to initiate, sustain, and move forward with obesity treatment.
  • 0.75 AMA PRA Category 1 Credit

Pages